Blood product use for radiological/nuclear trauma: product development and US regulatory considerations
Saved in:
| Main Authors: | Toby A Silverman, Annette M Shadiack, Kimberly A Hofmeyer, Ashley E Cecere, Derek L Eisnor, Corey M Hoffman, Shannon G Loelius, Aditiben Patel, Mary J Homer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-01-01
|
| Series: | Trauma Surgery & Acute Care Open |
| Online Access: | https://tsaco.bmj.com/content/9/Suppl_1/e001123.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Strategic and Technical Considerations in Manufacturing Viral Vector Vaccines for the Biomedical Advanced Research and Development Authority Threats
by: Lindsay A. Parish, et al.
Published: (2025-01-01) -
Epigenetic and gene regulatory functions of small RNAs
by: Cecere, Germano
Published: (2023-12-01) -
Implementation of a quality management system for decentralized manufacturing of cell and gene therapy products - technical and regulatory considerations
by: Heiko von der Leyen, et al.
Published: (2025-08-01) -
Management Considerations for Wheat Production in Florida
by: David L. Wright, et al.
Published: (2007-11-01) -
Management Considerations for Wheat Production in Florida
by: David L. Wright, et al.
Published: (2013-11-01)